<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a 50-year-old man who developed therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> after treatment with <z:chebi fb="0" ids="4911">etoposide</z:chebi>-including chemotherapy for extratesticular <z:mpath ids='MPATH_310'>germ cell tumor</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Chromosomal analysis showed inversion 11 (p15q22) translocation </plain></SENT>
<SENT sid="2" pm="."><plain>Reverse transcriptase-polymerase chain reaction amplification of patient <z:chebi fb="40" ids="33697">RNA</z:chebi> showed a fusion transcript of nucleoporin gene NUP98, and putative DEAD-box <z:chebi fb="40" ids="33697">RNA</z:chebi> helicase gene DDX10 </plain></SENT>
<SENT sid="3" pm="."><plain>NUP98 is implicated in the transformation through aberrant nucleocytoplasmic transport </plain></SENT>
<SENT sid="4" pm="."><plain>DDX10 is suggested to be involved in ribosome assembly </plain></SENT>
<SENT sid="5" pm="."><plain>The NUP98-DDX10 fusion transcript may promote the development of secondary <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> caused by DNA-<z:chebi fb="0" ids="50750">topoisomerase II inhibitors</z:chebi> through aberrant nucleocytoplasmic transport and/or alteration in ribosome assembly </plain></SENT>
</text></document>